Dose-dependent von Willebrand Factor inhibition by aptamer BB-031 correlates with thrombolysis in a microfluidic model of arterial occlusion
Open Access Publication
Rights and Permissions
Shea, S.M.; Thomas, K.A.; Rassam, R.M.G.; Mihalko, E.P.; Daniel, C.; Sullenger, B.A.; Spinella, P.C.; Nimjee, S.M. Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals 2022, 15, 1450. https://doi.org/10.3390/ph15121450 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Shea, Susan M; Thomas, Kimberly A; Rassam, Rassam M G; Mihalko, Emily P; Daniel, Christina; Sullenger, Bruce A; Spinella, Philip C; and Nimjee, Shahid M, "Dose-dependent von Willebrand Factor inhibition by aptamer BB-031 correlates with thrombolysis in a microfluidic model of arterial occlusion." Pharmaceuticals. 15, 12. 1450 (2022).
Supplemental material is available for this article at publisher site.